Vertex, Roche, KRAS, SpudCell synthetic cell: Readout Newsletter

by AiNewsBlog Jul, 05

written by AiNewsBlog Jul, 05 0 comments

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hi! As ever, lots going on in the light-speed world of biotech. The sector’s rally is gathering steam, the FDA’s AI flexibility is getting lost in translation, and Democrats lose a seasoned biopharma policymaker.

But I’m still reeling from that synthetic biology SpudCell Matt Herper wrote about.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

AiNewsBlog

Wall Street Analysts Are Predicting Something Never Seen Before, and It Should Come as a Huge Warning for Investors

Leave a Comment Cancel Reply

Name	Price	7d %	Volume
Bitcoin btc	$62,528	4.01%	$17,487,090,645
Ethereum eth	$1,752	10.93%	$11,264,295,866
XRP xrp	$1.13	7.66%	$1,677,145,521
Solana sol	$80	11.09%	$1,657,645,069
Dogecoin doge	$0.075	2.48%	$575,706,262

At Srivax, we believe in delivering fast, accurate, and relevant news to empower, inform, and engage our readers across the globe. We are an independent digital news platform built for the modern world — where information moves fast, and truth matters.